Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5a9f51ef690ed8682c3cf2c41ec50c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8268e39ce70ff2ad19742e2a21d5a90c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-14001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-26 |
filingDate |
1996-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c41ec386b0e61b8a1b1db2a8155b63d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3be740f9880dd31dc686cf01d5fa4dde http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01e987ad590086af71b450604f7d7d6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_517662217970f915053399b0c52ed588 |
publicationDate |
2004-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1475639-A2 |
titleOfInvention |
Tumour-specific P450 protein |
abstract |
The discovery that CYP1B1 protein is detectable in a wide range of human cancers ofndifferent histogenetic types, but is not detectable in non-cancerous tissues, gives rise tondiagnostic methods for detecting tumours based on this protein as a marker, and to thenpossibility of tumour therapies involving the protein. A diagnostic method may include thensteps of: (a) obtaining from a patient a tissue sample to be tested for the presence of cancerncells: (b) producing a prepared sample in a sample preparation process; (c) contacting thenprepared sample with an antibody that reacts with human CYP1B1 protein; and (d) detectingnbinding of the antibody to CYP1B1 protein in the prepared sample. |
priorityDate |
1995-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |